Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Aptamers come of age - at last.

Author information

Affiliations

  • 1. Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.
      Authors
    • Bunka DH 1
    (1 author)

ORCIDs linked to this article

Nature reviews. Microbiology, 01 Aug 2006, 4(8):588-596
https://doi.org/10.1038/nrmicro1458 PMID: 16845429 

Review

Abstract 

Nucleic-acid aptamers have the molecular recognition properties of antibodies, and can be isolated robotically for high-throughput applications in diagnostics, research and therapeutics. Unlike antibodies, however, they can be chemically derivatized easily to extend their lifetimes in biological fluids and their bioavailability in animals. The first aptamer-based clinical drugs have recently entered service. Meanwhile, active research programmes have identified a wide range of anti-viral aptamers that could form the basis for future therapeutics.

Full text links 

Read article at publisher's site: https://doi.org/10.1038/nrmicro1458

References 

Articles referenced by this article (100)

Show 10 more references (10 of 100)

Citations & impact 

Impact metrics

326
Citations
Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/3316289
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/3316289

Article citations

Go to all (326) article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.

Funding 

Funders who supported this work.

Wellcome Trust